In the area of environmental diseases, the Group is a partner of the EXIMIOUS project. This project is part of the European Human Exposome Network and brings together 15 partner organizations from 7 European countries. Regarding lung transplant, we are going to study the role of the viral footprint in lung transplant patients and the role of cell free DNA. In respiratory sleep-disorders, our research focuses on the clinical consequences and diagnostic challenges of respiratory sleep-disorders and ventilation disorders. Regarding COPD, the group will coordinate a multicenter project to know the effectiveness of palliative cures in the final phases of the disease, and a project for the study of pathogenesis of COPD using molecular and computational biology techniques. The group is part of the Catalonian Referral Unit for Cystic Fibrosis, which maintains the Spanish registry of bronchiectasis and patients with a1-antitrypsin deficit.
eCORE
- Advanced Therapies and Advanced Interventions, Nanomedicine, Transplant & Donation
- Chronic, Prevalent Diseases & Aging
- Global Health
- Personalized Medicine, Innovative Diagnostics, Molecular Imaging & Digital Health
- Woman & Child Health & Rare Diseases
Team
Group Leader
Mª Jesús Cruz Carmona, Jaume Ferrer Sancho
Principal Investigator (PI)
Miriam Barrechenguren Fernández, Cristina Berastegui Garcia, Susana Gómez Olles, Manuel López Meseguer, Marc Miravitlles Fernández, Victor Monforte Torres, Xavier Muñoz Gall, Iñigo Ojanguren Arranz, Eva Polverino, Berta Saez Gimenez
Researchers
Antonio Álvarez Fernández, Irene Belmonte Mula, Carlos Bravo Masgoret, David Clofent Alarcón, Mario Culebras Amigo, María Luiza De Souza Galvao, Mª Ángeles Jiménez Fuentes, Mª José Jurado Luque, Karina Loor Reyes, Sergi Martí Beltran, Cèlia Milà Augé, Mercedes Pallero Castillo, Mª Antonia Ramón Belmonte, Christian Romero Mesones, Odile Romero Santo-Tomas, Gabriel Sampol Rubio, Julia Sampol Sirvent, Ana Villar Gómez
PhD Students
Cristina Aljama, Meritxell Boada, David Espejo, Almudena Felipe, Galo Granados, Ander Goitisolo, Victor Guerra, Marc Massa, Gerard Orriols, Mª Florencia Pilia, María Saez, Júlia Sampol, David Soler, Letizia Traversi, Marta Zapata
Lab Technicians
Ares de Moner, Janet Illa, Sonia López Rodríguez, Rosa Lloria Verges, Montserrat Murillo Andrés, Jordi Rabadan Carnicero, Saliha Omari
Nursing and Technical Staff
Roser Escobar Fornieles, Georgina Farago
Publications
Jose Soler-Cataluna , Miravitlles M, Fernandez-Villar A, Izquierdo JL, Garcia-Rivero JL, Cosio BG, Lopez-Campos JL, Agusti A
Exacerbations in COPD: a personalised approach to care
Lancet Respir Med 2023 Mar;11(3):224-226.
DOI: 10.1016/S2213-2600(22)00533-1
IF: 76.2
Loor K, Culebras M, Sansano I, Alvarez A, Sacanell J, Garcia-de-Acilu M, Berastegui C, Polverino E, Clofent D, de Gracia J
Lung allograft transbronchial cryobiopsy for critical ventilated patients: a randomised trial
Eur Respir J 2023;61(1):2102354
DOI: 10.1183/13993003.02354-2021
IF: 24.9
Romero-Mesones C, Cruz MJ, Alobid I, Barroso B, Arismendi E, Barranco P, Betancor D, Bobolea I, Cardaba B, Curto E, Domenech G, Dominguez-Ortega J, Espejo D, Gonzalez-Barcala FJ, Luna-Porta JA, Martinez-Rivera C, Mendez-Brea P, Mullol J, Olaguibel JM, Picado C, Plaza V, Pozo VD, Quirce S, Rial MJ, Rodrigo-Munoz JM, Sastre J, Serrano S, Soto-Retes L, Valero A, Valverde-Monge M, Munoz X
Disposition of work-related asthma in a Spanish asthma cohort: comparison of asthma severity between employed and retired workers
J Allergy Clin Immunol Pract. 2023 Nov;11(11):3407-3413.e1.
DOI: 10.1016/j.jaip.2023.06.040
IF: 14.2
Miravitlles M, Turner AM, Torres-Duran M, Tanash H, Rodriguez-Garcia C, Lopez-Campos JL, Chlumsky J, Guimaraes C, Rodriguez-Hermosa JL, Corsico A, Martinez-Gonzalez C, Hernandez-Perez JM, Bustamante A, Parr DG, Casas-Maldonado F, Hecimovic A, Janssens W, Lara B, Barrecheguren M, Gonzalez C, Stolk J, Esquinas C, Clarenbach CF
Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries: EARCO international registry
Eur Respir J. 2023 Mar 30;61(3):2201949.
DOI: 10.1183/13993003.01949-2022
IF: 24.9
Chalmers JD, Aliberti S, Altenburg J, Blasi F, Clarke C, Chotirmall SH, Crichton ML, Dhar R, Goeminne P, Haworth C, Loebinger MR, Lorent N, Polverino E, Ringshausen FC, Shoemark A, Shteinberg M, Sibila O, Spinou A, Welte T
Transforming clinical research and science in bronchiectasis: EMBARC3, a European Respiratory Society Clinical Research Collaboration
Eur Respir J. 2023 Jun 29;61(6):2300769.
DOI: 10.1183/13993003.00769-2023
IF: 24.9
Projects
Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome (EXIMIOUS)
Principal Investigator: María Jesús Cruz. CoIP: Xavier Muñoz Gall
Agency: European Commission
Funding: 395,500 €
Period: 2020 - 2024
Characterisation and risk factors of PULmonary SEquelae in patients discharged after COVID-19 pneumonia (PULSE-COVID)
Principal Investigator: Xavier Muñoz Gall. CoIP: Marc Miravitlles
Agency: Instituto de Salud Carlos III. Fis PI21/01046
Funding: 135,520 €
Period: 2022 - 2024
MicroRNA expression profiles in asthmatic patients with different disease phenotypes exposed to pollutants
Principal Investigator: María Jesús Cruz
Agency: Instituto de Salud Carlos III. Fis PI21/01346
Funding: 141,570 €
Period: 2022 - 2024
Asthmatic exacerbations of viral origin and their impact on different asthmatic phenotypes: Etiology, immunological and inflammatory mechanisms
Principal Investigator: Iñigo Ojanguren Arranz
Agency: Instituto de Salud Carlos III. Fis PI21/01100
Funding: 75,020 €
Period: 2022 - 2024
Non-invasive biomarkers of chronic dysfunction in lung transplantation
Principal Investigator: Cristina Berastegui / Susana Gomez
Agency: Instituto de Salud Carlos III (PI22/01103)
Funding: 117,370 €
Period: 2023 - 2025
